Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Patel, Jyoti D.
Professor
Bio
I am a medical oncologist with expertise in clinical and translational research in thoracic cancers and clinical drug development. I have led multiple clinical trials with novel drugs at all levels, f... [more]
Peter, Marcus
Professor
Bio
Dr. Peter has been working in the apoptosis and death receptor field for 19 years. His initial work in 1995 described the first multiprotein complex in apoptosis, the CD95 death-inducing signaling com... [more]
Platanias, Leonidas C.
Professor
Bio
Dr. Platanias' laboratory is focused on studying abnormalities in signal transduction pathways in malignant myeloid cells. The ultimate goal of the work in Dr. Platanias' laboratory is to identify int... [more]
Pollack, Seth
Associate Professor
Bio
The goal of my research is to cure patients with advanced sarcomas with immunotherapy. My research has mainly focused at targeting the immunogenic protein NY-ESO-1 which is highly expressed in certain... [more]